PROGNOSTIC VALUE OF TUMOR NECROSIS FACTOR-ALPHA IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
https://doi.org/10.15789/1563-0625-2016-5-489-494
Abstract
About the Authors
E. N. ZotinaRussian Federation
PhD (Medicine), Junior Research Associate, Clinical Research Department,
610027, Kirov, Krasnoarmeyskaya str., 72
T. P. Zagoskina
Russian Federation
PhD (Medicine), Associate Professor, Department of Hospital Therapy,
Kirov
V. I. Shardakov
Russian Federation
PhD, MD (Medicine), Professor, Head, Laboratory of Leukemia Immunology,
Kirov
A. V. Yovdy
Russian Federation
PhD, MD (Medicine), Professor, Head, Laboratory of Leukemia Immunology,
Kirov
G. A. Zaitseva
Russian Federation
PhD, MD (Medicine), Professor, Head of Research Direction,
Kirov
References
1. Жевак Т.Н., Чеснокова Н.П., Шелехова Т.В. Закономерности изменений цитокинового статуса при хроническом лимфолейкозе и их роль в патогенезе прогрессирующих форм заболевания // Саратовский научно-медицинский журнал, 2012. Т. 8, № 2. С. 203-209. [Zhevak T.N., Chesnokova N.P., Schelekhova T.V. [Regularities of cytokine status changes in chronic lymphocytic leukaemia and their role in pathogenesis forms of disease. Saratovskiy nauchno-meditsinskiy zhurnal = Saratov Journal of Medical Scientific Research, 2012, Vol. 8, no 2, pp. 203-209. (In Russ.)]
2. Кетлинский С.А., Симбирцев А.С. Цитокины. СПб.: Фолиант, 2008. 552 с. [Ketlinsky S.A., Simbirtsev A.S. Cytokines]. St. Petersburg: Foliant, 2008. 552 p.
3. Волкова М.А. Клиническая онкогематология. М.: Медицина, 2007. 1120 с. [Volkova M.A. Clinical Oncohematology]. Moscow: Medicine, 2007. 1120 p.
4. Balkwill F., Joffroy C. TNF: a tumor-suppressing factor or tumor-promoting factor? Future Oncology, 2010, Vol. 6, no. 12, pp. 1833-1836.
5. Bojarska-Junak A., Hus I., Szczepanek E.W., Dmoszynska A., Rolinski J. Peripheral blood and bone marrow TNF and TNF receptors in early and advanced stages of B-CLL in correlation with ZAP-70 protein and CD38 antigen. Leukemia Research, 2008, Vol. 32, no 2, рр. 225-233.
6. Ferrajoli A., Keating M.J., Manshouri T., Giles F.J., Dey A., Estrov Z., Koller C.A., Kurzrock R., Thomas D.A., Faderl S., Lerner S., O'Brien S., Albitar M. The clinical significance of tumor necrosis factor-α plasma level in patients having chronic lymphocytic leukemia. Blood, 2002, Vol. 100, no. 4, pp. 1215-1219.
7. Hallek M., Cheson B.D., Catovsky D., Caligaris F., Dighiero G., Dohner H., Hillmen P., Keating M.J., Montserrat E., Rai K.R., Kipps T.J., International Workshop on Chronic Lymphocytic Leukemia. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood, 2008, Vol. 111, no 12, pp. 5446-5456.
8. Klein U., Dalla-Favera R. New insights into the pathogenesis of chronic lymphocytic leukemia. Seminars in Cancer Biology, 2010, Vol. 20, no. 6, pp. 377-338.
9. Singer M.K., Assem M., Abdel Ghaffar A.B., Morcos N.Y. Role of TNF-alpha as a survival prognostic marker in chronic lymphocytic leukemia patients. The Egyptian Journal of Immunology, 2011, Vol. 18, no. 2, pp. 51-60.
Review
For citations:
Zotina E.N., Zagoskina T.P., Shardakov V.I., Yovdy A.V., Zaitseva G.A. PROGNOSTIC VALUE OF TUMOR NECROSIS FACTOR-ALPHA IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. Medical Immunology (Russia). 2016;18(5):489-494. (In Russ.) https://doi.org/10.15789/1563-0625-2016-5-489-494